Awards
Medical, Pharmaceutical and Life Sciences
With expertise in, and knowledge of, Japanese pharmaceutical, medical device, food, medical, research and other various life sciences related regulations, we provide high-quality legal services to international and domestic pharmaceutical companies and medical device manufacturers, medical data and digital health businesses, drug wholesalers and retailers, medical and pharmaceutical service providers, food and beverages companies, as well as laboratories, research institutions, and other businesses related to the health and lives of people and other living things in the broad life sciences sector, including regenerative medicine products.
Based on our specialized knowledge and knowhow of the relevant regulations, we advise on and assist with a wide variety of regulatory matters, including regulatory interpretation and compliance issues, communication and interaction with Japanese regulatory authorities, clinical trials and clinical research, drug examinations, licenses and permits, NHI price listings, advertisements and promotional activities, as well as recalls, regulatory inspections, crisis management and internal investigations for potential misconduct or violations.
By utilizing our extensive knowledge and experience with respect to corporate, M&A, intellectual property, antitrust and competition, dispute resolution, cyber security, data protection and privacy, finance, real estate, labor law and other various business laws, we provide a wide range of services (including deal structuring, due diligence, contract drafting/negotiations and dispute resolution) in connection with various business activities related to the life sciences sector, such as mergers and acquisitions, alliances, licensing, business startups, facilities construction, financing and other commercial transactions.
Awards
Medical, Pharmaceutical and Life Sciences Related Awards
Topics
Medical, Pharmaceutical and Life Sciences Related Topics
Seminars
Medical, Pharmaceutical and Life Sciences Related Seminars
-
September 14, 2025 (Sun) 11:30 - 13:00Pharma II – So Do I – Litigating Biosimilars(Panel Discussion)
- Takahiro Hatori (Panelist)
PACIFICO Yokohama North
- Intellectual Property
- Dispute Resolution
-
September 10, 2025 (Wed) 15:00 - 16:30The 2025 Revisions to the Pharmaceuticals and Medical Devices Act ― Impact on the Life Sciences and Healthcare Industry and Remaining Challenges ―
- Kensuke Suzuki
- Masanori Tosu
- Tomoharu Hagiwara
Nagashima Ohno & Tsunematsu Tokyo Office
- Pharmaceutical and Healthcare
- Medical, Pharmaceutical and Life Sciences
-
June 12, 2025 (Thu) 14:00 - 15:00Legal Practice for Startups in the Middle-Late Stage
- Shuichi Nishimura
- Makoto Saito
- Kohei Mano
Online (Live & On-Demand)
- M&A
- Private Equity/Venture Capital and Startups
-
June 23, 2025 (Mon) 14:00 - 16:00Generative AI and Law -The 3rd JaDHA Open Seminar
- Keiji Tonomura
- Masanori Tosu
- Mamu Inoue (JaDHA)
Nagashima Ohno & Tsunematsu Tokyo Office / Online (Live)
- Pharmaceutical and Healthcare
- Medical, Pharmaceutical and Life Sciences
Publications
Medical, Pharmaceutical and Life Sciences Related Publications
-
Newsletters
First IP High Court Decision on Patent Linkage and Unfair Competition
Kenji Tosaki, Takahiro Hatori, Nozomi Kato (Co-author)
- Intellectual Property
- Dispute Resolution
-
Newsletters
Intellectual Property High Court orders generic drug companies to pay approximately JPY 21.7 billion in total in a patent infringement lawsuit (Judgment rendered May 27, 2025)
Kenji Tosaki, Ryo Tonomura (Co-author)
- Dispute Resolution
- IP Disputes
- Intellectual Property
-
Articles
Medical Tourism into Japan: Can Japan Ride the Big Wave?
(June 2025)
Shin Koike
- Medical, Pharmaceutical and Life Sciences
-
Newsletters
Tokyo District Court denies patent infringement claim in a case addressing the scope of a patent during its extended term (May 15, 2025)
Kenji Tosaki, Takahito Hirayama (Co-author)
- Dispute Resolution
- IP Disputes
- Intellectual Property